Answers are grounded in this paper and cite their sources.
Low urinary tract symptoms (LUTS) are common, very bothersome and with increased frequency in aging male population. Apart from voiding symptoms many men are struggling with moderate and severe storage symptoms, which influence dramatically their quality of life. One of the treatment options is pharmacotherapy, where several drug groups are available nowadays – among them α1-blockers and antimuscarinics. While every group has its advantages and side effects, the combination of those two have shown increased efficacy and acceptable safety when used in the good selected population of patients with combined voiding and storage LUTS.
No takes yet. Share an insight, caveat, or question.
Boris Mladenov (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: